Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-16

Clinical Trial Update: Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of radiation therapy with irinotecan in patients with colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Camptosar (irinotecan)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED